Cargando…

Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review

The novel coronavirus, SARS-CoV-2, or 2019-nCoV, which originated in Wuhan, Hubei province, China in December 2019, is a grave threat to public health worldwide. A total of 3,672,238 confirmed cases of coronavirus disease 2019 (COVID-19) and 254,045 deaths were reported globally up to May 7, 2020. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Gi Uk, Song, Hanra, Yoon, Gun Young, Kim, Doyoun, Kwon, Young-Chan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381222/ https://www.ncbi.nlm.nih.gov/pubmed/32765482 http://dx.doi.org/10.3389/fmicb.2020.01723

Ejemplares similares

SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death
por: Jeong, Gi Uk, et al.
Publicado: (2022)

Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung
por: Shin, Hye Jin, et al.
Publicado: (2021)

Comparison of Plaque Size, Thermal Stability, and Replication Rate among SARS-CoV-2 Variants of Concern
por: Jeong, Gi Uk, et al.
Publicado: (2021)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants
por: Li, Tingting, et al.
Publicado: (2022)

Genomic surveillance of genes encoding the SARS-CoV-2 spike protein to monitor for emerging variants on Jeju Island, Republic of Korea
por: Ha, Young-Ran, et al.
Publicado: (2023)

Characterization of host substrates of SARS-CoV-2 main protease
por: Melano, Ivonne, et al.
Publicado: (2023)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis
por: Fu, Yu, et al.
Publicado: (2021)

Therapeutic developments for SARS-CoV-2 infection—Molecular mechanisms of action of antivirals and strategies for mitigating resistance in emerging variants in clinical practice
por: Săndulescu, Oana, et al.
Publicado: (2023)

Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
por: Liu, Mingtao, et al.
Publicado: (2023)

Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection
por: He, Li-Hong, et al.
Publicado: (2020)

Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics
por: Khalid, Zunera, et al.
Publicado: (2022)

ABO Blood Group Incompatibility Protects Against SARS-CoV-2 Transmission
por: Boukhari, Rachida, et al.
Publicado: (2022)

What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
por: Martinez, Miguel Angel
Publicado: (2022)

An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2
por: Thapa, Himadri B., et al.
Publicado: (2021)

Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022)

Corrigendum: Identification of novel therapeutic candidates against SARS-CoV-2 infections: An application of RNA sequencing toward mRNA based nanotherapeutics
por: Khalid, Zunera, et al.
Publicado: (2022)

High Level of SARS-CoV-2 Infection in Young Population Is a Predictor for Peak Incidence
por: Choi, Haeyoun, et al.
Publicado: (2022)

Increase in Viral Load in Patients With SARS-CoV-2 Delta Variant Infection in the Republic of Korea
por: Kim, Jeong-Min, et al.
Publicado: (2022)

An Ensemble Matrix Completion Model for Predicting Potential Drugs Against SARS-CoV-2
por: Li, Wen, et al.
Publicado: (2021)

Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients
por: Zhang, Haiying, et al.
Publicado: (2022)

Ocular tropism of SARS-CoV-2 in animal models with retinal inflammation via neuronal invasion following intranasal inoculation
por: Jeong, Gi Uk, et al.
Publicado: (2022)

Molecular epidemiology and genetic characterization of SARS-CoV-2 in Kuwait: A descriptive study
por: Madi, Nada, et al.
Publicado: (2022)

Genomic characterization of SARS-CoV-2 in Egypt: insights into spike protein thermodynamic stability
por: Jalal, Deena, et al.
Publicado: (2023)

Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro
por: Clementi, Nicola, et al.
Publicado: (2020)

Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future
por: Rehman, Mubasher, et al.
Publicado: (2020)

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
por: Eweas, Ahmad F., et al.
Publicado: (2021)

Potential of Bacillus subtilis Against SARS-CoV-2 – A Sustainable Drug Development Perspective
por: Khodavirdipour, Amir, et al.
Publicado: (2022)

SARS-CoV-2 and gastrointestinal diseases
por: Sha, Ailong, et al.
Publicado: (2023)

Characterization of a Lytic Bacteriophage vB_SurP-PSU3 Infecting Staphylococcus ureilyticus and Its Efficacy Against Biofilm
por: Kwon, Hyemin, et al.
Publicado: (2022)

Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant
por: Ryu, Dong-Kyun, et al.
Publicado: (2021)

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
por: Klasse, PJ, et al.
Publicado: (2020)

Hold Breath: Autonomic Neural Regulation of Innate Immunity to Defend Against SARS-CoV-2 Infection
por: Wang, Changle, et al.
Publicado: (2022)

An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2
por: Amarilla, Alberto A., et al.
Publicado: (2021)

Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections
por: He, Yu, et al.
Publicado: (2020)

Uncovering Novel Viral Innate Immune Evasion Strategies: What Has SARS-CoV-2 Taught Us?
por: Tay, Douglas Jie Wen, et al.
Publicado: (2022)

Evaluation of the presence of SARS-CoV-2 in vaginal and anal swabs of women with omicron variants of SARS-CoV-2 infection
por: Liu, Ding, et al.
Publicado: (2022)

Therapeutic strategy targeting host lipolysis limits infection by SARS-CoV-2 and influenza A virus
por: Baek, Yeong-Bin, et al.
Publicado: (2022)

The Potential Intermediate Hosts for SARS-CoV-2
por: Zhao, Jie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n4mdb4vk9dl0s5q698nvditamu